Supporting Your Biomarker Journey
Cerba Research has extensive experience in developing IHC protocols from preclinical models to validating laboratory-developed tests for clinical trials. Our science-driven histology experts can provide complete and efficient IHC assay development, optimization, transfer, and fit-for-purpose validation. This allows you to take your study to its goal, whether it calls for simplex or multiplex immunohistochemistry protocol(s).
Discover The Art of Histopathology book
Our IHC expert scientist team will consult and work with you on your specific needs.
Flexible in our approach and delivery, we provide timely and cost-effective solutions to meet your clinical and commercial objectives.
A Biomarker Journey in Immuno-oncology Utilizing IHC
With immunohistochemistry (IHC) technology, biomarkers can be identified in tumor biopsies. IHC provides the possibility to better understand biomarker mechanisms in the tumor’s environment.
Brochure – Cerba Research IHC Biomarkers
Reach out to our experts to see how we can help you with your Immunohistochemistry needs!Contact Us